PharmaVoice Covers Raleigh as Pharma’s Next Manufacturing Hub

PharmaVoice is a leading digital platform for the pharmaceutical industry that reaches over 93,000 decision-makers. Recently, the publication covered Raleigh’s recent boom in billions of pharmaceutical manufacturing investments.

“Last year alone we had announcements of manufacturers, either setting up their operations here or expanding operations here, in the amount of a little over $10 billion of announced projects and about 14,000 jobs,” said Doug Edgeton, president and CEO of North Carolina Biotechnology Center.”  

The article covers the momentum in Raleigh’s life science sector and notes key drivers being talent, training, the cost of doing business, and space.

“The life sciences sector has been building a steady presence in Raleigh for decades, but that momentum has picked up in recent years, especially in biomanufacturing. And the area’s top-tier education system, built-in workforce development programs, lower costs and bountiful space are helping transform it into one of the country’s emerging biotech hubs.”

The article is a fantastic representation of the trajectory of the life sciences industry and the key stakeholders driving its momentum.

You can read the full article on PharmaVoice.